This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Buchmiller, C. E. Articles by Hensley, C. E. Search for Related Content PubMed PubMed Citation Articles by Buchmiller, C. E. Articles by Hensley, C. E., II Social Bookmarking                         What's this?

Liver Dysfunction and Energy Source: Results of a Randomized Clinical Trial

Veterans Affairs Medical Center, Iowa City

Rachel L. Kleiman-Wexler, PHARMD

Veterans Affairs Medical Center, Iowa City

Kimberly S. Ephgrave, MD

Veterans Affairs Medical Center, Iowa City

Brenda Booth, PHD

Veterans Affairs Medical Center, Iowa City

Carl E. Hensley, II, RPH

Veterans Affairs Medical Center, Iowa City

Controversy still exists regarding the role of the carbohydrate:fat ratio on liver function abnormalities associated with the administration of total parenteral nutrition (TPN). We designed a prospective clinical trial comparing standard carbohydrate-based TPN (8.5% amino acids, 50% dextrose, 7.5% of total calories from lipids) with an isocaloric lipid-based TPN (8.5% amino acids, 30% dextrose, 40% of total calories from lipids) in 43 patients exclusively receiving TPN 2 weeks. Energy needs were calculated as basal energy expenditure X 1.5. The mean daily calorie intake for patients who obtained carbohydrate-based TPN (CHO) was 2227 kcal, whereas the lipid-based TPN (LIP-CHO) group achieved a mean of 2310 kcal. Patients with preexisting liver disease were excluded. There was no significant difference in age or diagnosis between the groups. We monitored total bilirubin, direct bilirubin, alkaline phosphatase, -glutamyl transferase, lactic dehydrogenase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase. Initial liver-associated tests did not vary significantly between groups. Group mean values after 2 weeks of TPN were significantly different for total bilirubin (1.5 mg/dL in the CHO group compared with 0.7 in the LIP-CHO group, p < .05) and direct bilirubin (0.8 mg/dL in the CHO group compared with 0.3 mg/dL in the mixed substrate group, p < .05). Differences in mean values between groups were also noted for serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, and lactic dehydrogenase. In conclusion, this prospective trial reveals that the use of a balanced energy source TPN solution prevents the abnormalities in liver-associated tests commonly associated with TPN. This study differs from previous trials in that overfeeding was avoided in both groups and most liver-associated tests were within normal limits in patients with mixed calorie source TPN. (Journal of Parenteral and Enteral Nutrition 17:301-306, 1993)

Journal of Parenteral and Enteral Nutrition, Vol. 17, No. 4, 301-306 (1993)
DOI: 10.1177/0148607193017004301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				American Society for Parenteral and Enteral Nutrit Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients JPEN J Parenter Enteral Nutr, January 1, 2002; 26(1_suppl): 1SA - 138SA. [PDF]

				W. Druml, M. Fischer, and K. Ratheiser Use of Intravenous Lipids in Critically Ill Patients With Sepsis Without and With Hepatic Failure JPEN J Parenter Enteral Nutr, July 1, 1998; 22(4): 217 - 223. [Abstract] [PDF]